Overview > The ELMA Foundation > AIDS-Free
Focus Area:
AIDS-Free
We succeed when the number of new HIV infections in children is reduced, and when countries are on track to eliminate pediatric AIDS by 2030.
Unfinished Business is a coordinated effort to find HIV-positive children and adolescents living in Uganda and South Africa and ensure that they are linked to quality support services and life-long treatment.
Current Investments
Project support to strengthen sub-national level clinical, laboratory, and leadership capacity to implement the integrated HIV/AIDS service framework, and enhance health workers’ clinical practices to promote greater efficiency
Project support to enhance sub-national capacity to implement the integrated HIV service framework and strengthen health workers' clinical practices through in-service training and mentorship
Project support to increase demand for and uptake of adolescent HIV and sexual and reproductive health services, with a particular focus on pre-exposure Prophylaxis (PrEP), across two regions
Project support to provide technical assistance to the Ministry of Health and strengthen primary health care structures for the delivery of integrated HIV prevention and care services in Kampala
Project support for a Phase 1 clinical trial of new broadly neutralizing anti-HIV monoclonal antibodies (bnAbs) to assess their safety and potential to prevent vertical HIV transmission in infants
Project support for a phase 3 clinical trial to demonstrate the efficacy of a shortened treatment regimen for children with TB
Project support for a clinical study to evaluate the use of a variety of rapid diagnostic tools to detect TB in high-risk children in the Eastern Cape
Project support for the Phase 1 clinical trial of a novel HIV vaccine for infants with perinatal HIV exposure who are HIV negative at birth
Project support to finalize a four-year collaborative study to understand the effects of HIV on the central nervous system and the development of lymphatic reservoirs in children and adolescents, to enable future HIV cure efforts
Project support to develop manufacturing technology for anti-retroviral active pharmaceutical ingredients to localize the production of key HIV products
Project support to sustain access to care for key and priority populations with a focus on HIV prevention
Project support to sustain access to care for key and priority populations, with a focus on HIV prevention
Project support to sustain access to care for key and priority populations, with a focus on HIV prevention
Project support to sustain essential HIV services and retain 155,484 people living with HIV in care through technical support and financial assistance to five high-burden districts in Rwenzori and Bunyoro regions
Project support to the management of WHO's Global Accelerator for Pediatric Formulations (GAP-f) network, which is focused on accelerating access to safe, effective, quality, affordable pediatric medicines
General support to an organization that strengthens pediatric and adolescent HIV service delivery by providing technical support and accelerated access to optimal pediatric formulations in high-burden countries
General support for an organization providing technical assistance to governments and partners to implement a peer-led service delivery model supporting children and adolescents living with HIV
